tumor samples; adjacent nontumor samples
BEAS-2B; PC9; A549; H1975; H1299; H1650; H441
-
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); ceRNA regulation (promotes); other pathway/process (other)
RNA-seq; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Transfection; CCK8; EdU Staining; Wound Healing Assay; Transwell Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry
circSPECC1 is up-regulated in LUAD/NSCLC tumors and promotes malignant phenotypes (proliferation, migration, invasion, adhesion). circSPECC1 knockdown increases osimertinib-induced apoptosis and restores TKI sensitivity, and a ceRNA network suggests it sponges miR-598-3p/miR-33a-3p/miR-497-5p/miR-369-3p to affect downstream mRNAs (e.g., TUBB1, BCHE, BNIP3, LHFPL6, SLC39A4).
0.6117
Circular RNA SPECC1 promoted tumorigenesis and osimertinib resistance in lung adenocarcinoma via a circular RNA-microRNA network.
combined biological and clinical study